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Abstract 
Purpose of review: We aim to illustrate the potential viability of MCTD as an underlying aetiology of Melkersson–
Rosenthal syndrome. The case is probably the first description available in the literature of the Melkersson–Rosenthal 
as an early manifestation of mixed connective tissue disease.
Recent findings: The Melkersson–Rosenthal syndrome consists of a triad of recurrent lip and/or face swelling, fis-
sured tongue, and intermittent facial palsy. Mixed connective tissue disease is a multisystemic disorder with overlap-
ping features of systemic lupus erythematosus, scleroderma, and polymyositis, and is differentiated from them by a 
high titer of antibodies to ribonucleoprotein. The paper presents a case report of Melkersson–Rosenthal syndrome 
with an onset in childhood that derived from vasculitis that turned out to be an early manifestation of mixed connec-
tive tissue disease. We used MRI to evaluate patient’s brain structure and Immunoblot Ena Profil 1 test to test serum 
autoantibodies level. The patient has a typical for Melkersson–Rosenthal syndrome triad of symptoms: bilateral facial 
nerve palsy, lingua plicata and facial oedema. Both TC and MRI of the head show no changes as well as laboratory 
tests except Anti-SS-A (Anti-Ro) and Anti-RNP autoantibody serum level that was highly positive.
Summary: Neurological involvement of the MCTD usually includes, according to the frequency of the occurrence, 
trigeminal neuralgia, headaches, sensorineural hearing, cerebral haemorrhage, transverse myelitis, cauda equina syn-
drome, retinal vasculitis, progressive multifocal encephalopathy, and demyelinating neuropathy. For clinical practice it 
is important to remember that Melkersson–Rosenthal syndrome can also be the neurological manifestation of MCTD, 
especially when accompanied by other systemic symptoms.
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Background
The Melkersson–Rosenthal syndrome consists of a triad 
of recurrent lip and/or face swelling, fissured tongue, and 
intermittent facial palsy. Mixed connective tissue disease 
is a multisystemic disorder with overlapping features of 
systemic lupus erythematosus, scleroderma, and polymy-
ositis, and is differentiated from them by a high titer of 
antibody to ribonucleoprotein [1].
The paper presents a case report of Melkersson–
Rosenthal syndrome with an onset in childhood that 
derived from vasculitis that turned out to be an early 
manifestation of mixed connective tissue disease.
Case report
Patient aged 38, female was admitted to the Neurol-
ogy Department of our Speciality Hospital in order to 
diagnose the occurrence of the upper limbs weakness 
localized mostly proximally with additional numbness 
sensation in the lower limbs. Apart from that the patient 
suffered from a recurrent alternate facial nerve palsy, diz-
ziness, intermittent fever, hypertension, obesity, coli lym-
phadenopathy, hipercholesterolemia, glucose intolerance, 
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The symptom of recurrent alternate facial nerve palsy 
first occurred at the age of 5 to return at the age of 18, 
30, and 32. There were no relevant factors in the gynae-
cological history—her periods were regular and mildly 
abundant.
The family history reveals that her 14-year-old daugh-
ter has lingua plicata (Fig.  1) and suffers from tongue 
numbness and ecchymoses on the palate and the oral 
mucous membrane. These symptoms would appear once 
a month and subside without treatment.
Closer examination revealed: an excessively smooth left 
nasolabial furrow (Fig. 2), trouble with both eye closure, 
lingua plicata, (Fig. 3), ecchymoses on the palate, and oral 
mucous membrane, the superficial deprivation feel of the 
face; muscle strength and tension were normal, also mus-
cle strength reflexes show no change; Romberg’s as well 
as Babinski’s signs were negative. At admission, a TC of 
the head was performed and no abnormality was shown. 
The MRI of the head had shown no change of the normal 
brain structure. The lumbar puncture was recommended 
as the next step and cerebrospinal fluid parameters were 
in the normal range.
As for the laboratory findings, a glucose intolerance 
and hipercholesterolemia were confirmed. Elisa test for 
Borrelia burgdorferi antibody was negative in both IgM 
and IgG class.
The results of basic laboratory tests, including blood 
morphology, CPK, CRP level, glucose, urinalysis, liver 
and kidney function tests, were normal. The results of 
electrocardiography were also normal. The level of IgA, 
IgG, IgM antibodies were within the range. There was no 
trace of Anti-RNP, Anti-Sm, Anti-SS-B, Anti-Scl 70, and 
Anti-Jo-1 in blood serum. High titers of Anti-SS-A were 
detected.
Based on these findings the immune deficiency was 
discluded, diagnose of vasculitis was stated and chloro-
quini phosphas was administered in a dosage of 250 mg 
per day. Symptoms like dizziness, intermittent fever, coli 
lymphadenopathy, limbs weakness with an additional 
numbness sensation, ecchymoses on the palate, and oral 
mucous membrane subsided completely after 4 weeks of 
the therapy.
Discussion
Mixed connective tissue disease is a multisystemic dis-
order with overlapping features of systemic lupus ery-
thematosus, scleroderma, and polymyositis, and is 
Fig. 1 Patient’s daughter. Lingua plicata (or fissured tongue). One of 
the triad of the symptoms of Melkersson–Rosenthal syndrome that 
consist of recurrent lip and/or face swelling, fissured tongue, and 
intermittent facial palsy
Fig. 2 Patient. Smooth left nasolabial furrow. After bilateral facial 
nerve palsy patient is unable to smile
Fig. 3 Patient. Lingua plicata (or fissured tongue). One of the triad 
of the symptoms of Melkersson–Rosenthal syndrome that consist of 
recurrent lip and/or face swelling, fissured tongue, and intermittent 
facial palsy
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differentiated from them by a high titer of antibodies to 
ribonucleoprotein [1].
MCTD was first described by Sharp in 1972 and pub-
lished in The American Journal of Medicine. Three sets 
of the MCTD diagnostic criteria exist in clinical prac-
tice—those by Sharp, those by Alarcon-Segovii and Vil-
lareala, and those by Kasukawa [2].
Anti-RNP antibodies appear to be pathogenic, and 
their disappearance is associated with periods of remis-
sion in MCTD. The production of Anti-RNP antibodies 
may be induced by a molecular mimicry, possibly involv-
ing influenza B matrix protein, retroviral p30gag antigen, 
cytomegalovirus, and Epstein-Barr virus. The subclasses 
of Anti-RNP antibodies may be associated with different 
clinical scenarios. In addition, some HLA subtypes are 
associated with specific patterns of tissue injury in the 
presence of Anti-RNP antibodies [3].
The most frequent CNS manifestation is a trigeminal 
(fifth cranial) nerve neuropathy. Furthermore, neurological 
involvement of the MCTD usually includes, according to 
the frequency of the occurrence: headaches, sensorineural 
hearing, cerebral haemorrhage, transverse myelitis, cauda 
equina syndrome, retinal vasculitis, progressive multifo-
cal encephalopathy, and demyelinating neuropathy [4]. 
So far there was no publication regarding the connection 
between Melkersson–Rosenthal syndrome and MCTD.
As stated before, Melkersson–Rosenthal syndrome is 
a rare disease which includes a triad of symptoms: facial 
nerve palsy, lingua plicata, and facial oedema [5, 6]. Auto-
somal dominant inheritance with incomplete penetrance 
is well documented. The responsible gene was found on 
chromosome 9 p11 [7].
The aetiology is unknown; however, pathological 
specimens of a sick tissues demonstrate non-caseating 
granulomas grouped around the vessel space that could 
indicate that vessel inflammation is the most possible 
cause of Melkersson–Rosenthal syndrome [8]. Histologic 
evidence is not necessary for the diagnosis of Melkers-
son–Rosenthal syndrome. As shown in the patient’s his-
tory as well as one of the researches, total of 13 (29.5 %) 
patients with Melkersson–Rosenthal syndrome had a 
family history [9, 10].
As for our patient, as a child she suffered from the 
recurrent alternate facial nerve palsy which first occurred 
at the age of 5 to return at the age of 18, 30, and 32. When 
other symptoms like limbs weakness, dizziness, intermit-
tent fever, hypertension, coli lymphadenopathy, hiper-
cholesterolemia, hands, and ankles oedema appeared, a 
systemic disease was taken into consideration and diag-
nosis was stated.
In our opinion, our patient’s daughter suffers from 
oligosymptomatic form of Melkersson–Rosenthal syn-
drome, which is probably derived from vasculitis based 
on the occurrence of ecchymoses on the palate and oral 
mucous membrane. Because her symptoms were mild 
and subsided without treatment, we decided to choose to 
wait and devise a strategy.
Conclusion
This case illustrates the potential viability of MCTD as 
an underlying aetiology of Melkersson–Rosenthal syn-
drome and is probably the first description available in 
the literature of the Melkersson–Rosenthal as an early 
manifestation of a mixed connective tissue disease. For 
clinical practice it is important to remember that Melk-
ersson–Rosenthal syndrome can also be the neurological 
manifestation of MCTD, especially when accompanied 
by other systematic symptoms.
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